Medscape July 7, 2021
The COVID-19 pandemic jump-started a significant role for telemedicine in the routine follow-up of US patients with type 2 diabetes, based on insurance-claims records for more than 2.7 million American adults during 2019 and 2020.
During 2019, 0.3% of 1,357,029 adults with type 2 diabetes in a US claims database, OptumLabs Data Warehouse, had one or more telemedicine visits. During 2020, this jumped to 29% of a similar group of US adults once the pandemic kicked in, a nearly 100-fold increase, Sadiq Y. Patel, PhD, and coauthors write in a research letter published online July 6 in JAMA Internal Medicine.
The data show that telemedicine visits didn’t seem to negatively impact care, with A1c levels and medication fills remaining constant...
Today's Sponsors
Today's Sponsor